tresuvi 2,5 mg/ml
aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 2,5mg/ml - antitrombotice antiagregante plachetare
tresuvi 5 mg/ml
aop orphan pharmaceuticals gmbh - austria - treprostinilum - sol. perf. - 5mg/ml - antitrombotice antiagregante plachetare
rapibloc 20 mg/2 ml
aop orphan pharmaceuticals gmbh - austria - landiololum - conc. pt. sol. inj. - 20mg/2ml - agenti betablocanti betablocante selective
tadalafil aop 20 mg
genepharm s.a. - grecia - tadalafilum - compr. film. - 20mg - alte preparate urologice (incl. antispastice) medicamente pt. trat. disfunctiei erectile
rapibloc 20 mg/2 ml
aop orphan pharmaceuticals ag - austria - landiololum - conc. pt. sol. inj. - 20mg/2ml - agenti betablocanti betablocante selective
rapibloc 300 mg
aop orphan pharmaceuticals ag - austria - landiololum - pulb. pt. sol. perf. - 300mg - agenti betablocanti betablocante selective
besremi 250 mcg/0,5 ml
aop orphan pharmaceuticals ag - austria - ropeginterferon alfa-2b - sol. inj. in pen preumplut - 250mcg/0,5ml - cytokine si imunomodulatoare interferoni
rapibloc 600 mg
aop orphan pharmaceuticals ag - landiololum - pulb. pt. sol. perf. - 600mg - agenti betablocanti betablocante selective
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
besremi
aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - policitemia vera - imunostimulante, - besremi este indicat ca monoterapie la adulți pentru tratamentul policitemiei vera, fără simptomatic splenomegalie.